Dosimetric evaluation of a spinal cord dose‐limiting 3D‐CRT technique for radiotherapy of spinal metastases

BACKGROUND: To evaluate the possible advantages of a simple spinal cord (SC) dose‐limiting three‐dimensional conformal radiotherapy (3D‐CRT) technique in comparison to conventional two‐dimensional (2D) techniques and other 3D‐CRT techniques for spinal bone irradiation. METHODS: For 41 spinal target volumes, seven different techniques were evaluated, using a standard schedule of 30 Gy in 10 fractions. The SC dose‐limiting 3D‐CRT technique 1F2S‐18MV using a single posterior field (F) supplemented by two anterior segment fields (S) and 18‐MV photon beams was compared to two conventional 2D techniques (a single posterior field, PA, and two opposed anterior‐posterior fields, APPA), three other 3D‐CRT techniques (a single posterior field supplemented by four segment fields, 1F4S; two wedged fields, WD, and the SC dose‐limiting variant using 6 MV, 1F2S‐6MV) along with the original clinically applied plans. RESULTS: 1F2S‐18MV demonstrated notably better results for all target volume parameters compared to the conventional 2D techniques (p < 0.001). Limitation of the SC dose was significantly superior with 1F2S‐18MV in comparison to PA and APPA (SC Dmean: 28.9 ± 0.4 vs. 30.1 ± 0.6 Gy and 30.1 ± 0.4 Gy; SC Dmax: 30.9 ± 0.7 vs. 32.5 ± 1.0 Gy and 31.8 ± 0.7 Gy; SC D1cm(3): 30.1 ± 0.6 vs. 31.7 ± 0.9 Gy and 31.1 ± 0.6 Gy; p < 0.001). Likewise, lower mean SC doses with 1F2S‐18MV were observed in comparison to the more treatment time‐consuming 3D‐CRT techniques (1F4S, WD) and the original plans without relevant compromises on the dose homogeneity in the target volume and the dose exposure to the other OARs. CONCLUSION: In treatment planning of spinal metastases, simple variants of 3D‐CRT‐techniques like 1F2S‐18MV can offer a significant dose limitation to the SC while providing a sufficient dose coverage of the target volume. Especially in patients with favorable life expectancy and potential need for re‐irradiation, such SC dose‐limiting 3D‐CRT techniques may be a reasonable approach.